Virtus ETF Advisers LLC Chimerix Inc Transaction History

Virtus ETF Advisers LLC

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 12, 2022	SELL	$1.34 - $5.34 $34,807 - $138,711	-25,976 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$4.58 - $6.8 $7,044 - $10,458	-1,538 Reduced 5.59%	25,976 $119,000
Q4 2021 Feb 14, 2022	BUY	$5.23 - $7.18 $12,348 - $16,951	2,361 Added 9.39%	27,514 $177,000
Q3 2021 Nov 15, 2021	SELL	$5.94 - $8.75 $7,834 - $11,541	-1,319 Reduced 4.98%	25,153 $156,000
Q2 2021 Aug 10, 2021	BUY	$7.54 - $9.79 $199,598 - $259,160	26,472 New	26,472 $212,000

36.8M

72.2K

169K

Ticker CMRX
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 87,622,896
Market Cap $85M
Description
Chimerix, Inc., a biopharmaceutical company, develops medicines to enhance the lives of patients living with serious diseases. The company's approved product is TEMBEXA (brincidofovir), a lipid conjugate through inhibition of viral DNA synthesis that is developed as a medical countermeasure for smallpox. Its clinical stage development programs i...

Get notified when there are updates to the investment portfolio of Virtus ETF Advisers LLC, based on Form 13F filings with the SEC.

Stay updated on Virtus ETF Advisers LLC with notifications on news.